J07A

BACTERIAL VACCINES

Наименование на групата: WHO Collaborating Centre for Drug Statistics Methodology

Подгрупи

ATC класификацията е дърво. Тази категория се разделя на 7 подгрупи.

Лекарствени продукти в тази категория

21 продукта в тази категория и подгрупите ѝ.

Търговско име	Концентрация
Adacel	suspension for injection in pre-filled syringe
BCG Vaccine	0.05 mg
Bexsero	--¹ One dose (0.5 ml) contains: Recombinant Neisseria meningitidis group B NHBA fusion protein ¹, ², ³ 50 micrograms Recombinant Neisseria meningitidis group B NadA protein ¹, ², ³ 50 micrograms Recombinant Neisseria meningitidis group B fHbp fusion protein ¹, ², ³ 50 micrograms Outer membrane vesicles (OMV) from Neisseria meningitidis group B strain NZ98/254 measured as amount of total protein containing the PorA P1.4² 25 micrograms ¹ produced in E. coli cells by recombinant DNA technology ² adsorbed on aluminium hydroxide (0.5 mg Al³+) ³ NHBA (Neisseria Heparin Binding Antigen), NadA (Neisserial adhesin A), fHbp (factor H binding protein)
Boostrix	suspension for injection in pre-filled syringe
CAPVAXIVE	--¹ 1 dose (0.5ml) contains: Pneumococcal polysaccharide serotype 3¹ 4 μg Pneumococcal polysaccharide serotype 6A¹ 4 μg Pneumococcal polysaccharide serotype 7F¹ 4 μg Pneumococcal polysaccharide serotype 8¹ 4 μg Pneumococcal polysaccharide serotype 9N¹ 4 μg Pneumococcal polysaccharide serotype 10A¹ 4 μg Pneumococcal polysaccharide serotype 11A¹ 4 μg Pneumococcal polysaccharide serotype 12F¹ 4 μg Pneumococcal polysaccharide serotype 15A¹ 4 μg Pneumococcal polysaccharide from deOAc15B (de-O-acetylated serotype 15B¹) 4 μg Pneumococcal polysaccharide serotype 16F¹ 4 μg Pneumococcal polysaccharide serotype 17F¹ 4 μg Pneumococcal polysaccharide serotype 19A¹ 4 μg Pneumococcal polysaccharide serotype 20A¹ 4 μg Pneumococcal polysaccharide serotype 22F¹ 4 μg Pneumococcal polysaccharide serotype 23A¹ 4 μg Pneumococcal polysaccharide serotype 23B¹ 4 μg Pneumococcal polysaccharide serotype 24F¹ 4 μg Pneumococcal polysaccharide serotype 31¹ 4 μg Pneumococcal polysaccharide serotype 33F¹ 4 μg Pneumococcal polysaccharide serotype 35B¹ 4 μg ¹Conjugated to CRM197 carrier protein. CRM197 is a nontoxic mutant of diphtheria toxin (originating from Corynebacterium diphtheriae C7) expressed recombinantly in Pseudomonas fluorescens. 1 dose (0.5 mL) contains approximately 65 μg CRM197 carrier protein.
Diftet	suspension for injection
Dukoral	--¹ Each dose of vaccine suspension (3 ml) contains: - A total of 1.25x10¹¹ bacteria of the following strains: Vibrio cholerae O1 Inaba, classical biotype (heat inactivated) 31.25x10⁹ bacteria Vibrio cholerae O1 Inaba, El Tor biotype (formalin inactivated) 31.25x10⁹ bacteria Vibrio cholerae O1 Ogawa, classical biotype (heat inactivated) 31.25x10⁹ bacteria Vibrio cholerae O1 Ogawa, classical biotype (formalin inactivated) 31.25x10⁹ bacteria - Recombinant cholera toxin B subunit (rCTB) 1 mg
MenQuadfi	--¹ One dose 0.5 mL contains: Neisseria meningitidis group A polysaccharide² 10 micrograms Neisseria meningitidis group C polysaccharide² 10 micrograms Neisseria meningitidis group Y polysaccharide² 10 micrograms Neisseria meningitidis group W polysaccharide² 10 micrograms ²Conjugated to tetanus toxoid carrier protein 55 micrograms
Menveo	--¹ One dose (0.5 ml) contains: Meningococcal group A oligosaccharide 10 micrograms conjugated to Corynebacterium diphtheriae CRM197 protein 16.7 to 33.3 micrograms Meningococcal group C oligosaccharide 5 micrograms conjugated to Corynebacterium diphtheriae CRM197 protein 7.1 to 12.5 micrograms Meningococcal group W135 oligosaccharide 5 micrograms conjugated to Corynebacterium diphtheriae CRM197 protein 3.3 to 8.3 micrograms Meningococcal group Y oligosaccharide 5 micrograms conjugated to Corynebacterium diphtheriae CRM197 protein 5.6 to 10.0 micrograms
Nimenrix	--¹ Neisseria meningitidis serogroup A polysaccharide* 5 micrograms Neisseria meningitidis serogroup C polysaccharide* 5 micrograms Neisseria meningitidis serogroup W-135 polysaccharide* 5 micrograms Neisseria meningitidis serogroup Y polysaccharide* 5 micrograms *conjugated to tetanus toxoid carrier protein 44 micrograms
Pneumovax 23	solution for injection in pre-filled syringe
Prevenar 13	--¹ 1 dose (0.5 ml) contains: Pneumococcal polysaccharide serotype 1¹ 2.2 µg Pneumococcal polysaccharide serotype 3¹ 2.2 µg Pneumococcal polysaccharide serotype 4¹ 2.2 µg Pneumococcal polysaccharide serotype 5¹ 2.2 µg Pneumococcal polysaccharide serotype 6A¹ 2.2 µg Pneumococcal polysaccharide serotype 6B¹ 4.4 µg Pneumococcal polysaccharide serotype 7F¹ 2.2 µg Pneumococcal polysaccharide serotype 9V¹ 2.2 µg Pneumococcal polysaccharide serotype 14¹ 2.2 µg Pneumococcal polysaccharide serotype 18C¹ 2.2 µg Pneumococcal polysaccharide serotype 19A¹ 2.2 µg Pneumococcal polysaccharide serotype 19F¹ 2.2 µg Pneumococcal polysaccharide serotype 23F¹ 2.2 µg ¹ Conjugated to CRM₁₉₇ carrier protein, adsorbed on aluminium phosphate. 1 dose contains approximately 32 µg CRM₁₉₇ carrier protein and 0.125 mg aluminium.
Prevenar 20	--¹ 1 dose (0.5 mL) contains: Pneumococcal polysaccharide serotype 1¹ ² 2.2 μg Pneumococcal polysaccharide serotype 3¹ ² 2.2 μg Pneumococcal polysaccharide serotype 4¹ ² 2.2 μg Pneumococcal polysaccharide serotype 5¹ ² 2.2 μg Pneumococcal polysaccharide serotype 6A¹ ² 2.2 μg Pneumococcal polysaccharide serotype 6B¹ ² 4.4 μg Pneumococcal polysaccharide serotype 7F¹ ² 2.2 μg Pneumococcal polysaccharide serotype 8¹ ² 2.2 μg Pneumococcal polysaccharide serotype 9V¹ ² 2.2 μg Pneumococcal polysaccharide serotype 10A¹ ² 2.2 μg Pneumococcal polysaccharide serotype 11A¹ ² 2.2 μg Pneumococcal polysaccharide serotype 12F¹ ² 2.2 μg Pneumococcal polysaccharide serotype 14¹ ² 2.2 μg Pneumococcal polysaccharide serotype 15B¹ ² 2.2 μg Pneumococcal polysaccharide serotype 18C¹ ² 2.2 μg Pneumococcal polysaccharide serotype 19A¹ ² 2.2 μg Pneumococcal polysaccharide serotype 19F¹ ² 2.2 μg Pneumococcal polysaccharide serotype 22F¹ ² 2.2 μg Pneumococcal polysaccharide serotype 23F¹ ² 2.2 μg Pneumococcal polysaccharide serotype 33F¹ ² 2.2 μg ¹ Conjugated to CRM₁₉₇ carrier protein (approximately 51 μg per dose) ² Adsorbed on aluminium phosphate (0.125 mg aluminium per dose)
Synflorix	--¹ 1 dose (0.5 ml) contains: Pneumococcal polysaccharide serotype 1* ¹ 1 microgram Pneumococcal polysaccharide serotype 4* ¹ 3 micrograms Pneumococcal polysaccharide serotype 5* ¹ 1 microgram Pneumococcal polysaccharide serotype 6B* ¹ 1 microgram Pneumococcal polysaccharide serotype 7F* ¹ 1 microgram Pneumococcal polysaccharide serotype 9V* ¹ 1 microgram Pneumococcal polysaccharide serotype 14* ¹ 1 microgram Pneumococcal polysaccharide serotype 18C* ² 3 micrograms Pneumococcal polysaccharide serotype 19F* ³ 3 micrograms Pneumococcal polysaccharide serotype 23F* ¹ 1 microgram * adsorbed on aluminium phosphate 0.5 milligram Al³+ ¹ conjugated to protein D (derived from non-typeable Haemophilus influenzae) carrier protein 9-16 micrograms ² conjugated to tetanus toxoid carrier protein 5-10 micrograms ³ conjugated to diphtheria toxoid carrier protein 3- 6 micrograms
Tetadif	suspension for injection
Tetatox	suspension for injection
Trumenba	--¹ 1 dose (0.5 ml) contains: Neisseria meningitidis serogroup B fHbp subfamily A¹,²,³ 60 micrograms Neisseria meningitidis serogroup B fHbp subfamily B¹,²,³ 60 micrograms ¹ Recombinant lipidated fHbp (factor H binding protein) ² Produced in Escherichia coli cells by recombinant DNA technology ³ Adsorbed on aluminium phosphate (0.25 milligram aluminium per dose)
Typhim VI	0,5 ml
VacPertagen	--¹ One dose (0.5 ml) contains: Purified Bordetella pertussis antigens Recombinant Pertussis Toxin (PTgen )¹,² 5 micrograms Filamentous Haemagglutinin (FHA)¹ 5 micrograms ¹adsorbed on aluminum hydroxide, hydrated 0.3 milligrams Al³⁺ ²produced in Bordetella pertussis as a genetically detoxified PT (PTgen or rPT) by recombinant DNA technology Formaldehyde may be present in trace amounts as a manufacturing process residual.
Vaxchora	--¹ ¹One dose contains: Not less than 4 x 10E8 viable cells of Vibrio cholerae live, attenuated strain CVD 103-HgR
Vaxneuvance	--¹ One dose (0.5 mL) contains: Pneumococcal polysaccharide serotype 1¹,² 2.0 µg Pneumococcal polysaccharide serotype 3¹,² 2.0 µg Pneumococcal polysaccharide serotype 4¹,² 2.0 µg Pneumococcal polysaccharide serotype 5¹,² 2.0 µg Pneumococcal polysaccharide serotype 6A¹,² 2.0 µg Pneumococcal polysaccharide serotype 6B¹,² 4.0 µg Pneumococcal polysaccharide serotype 7F¹,² 2.0 µg Pneumococcal polysaccharide serotype 9V¹,² 2.0 µg Pneumococcal polysaccharide serotype 14¹,² 2.0 µg Pneumococcal polysaccharide serotype 18C¹,² 2.0 µg Pneumococcal polysaccharide serotype 19A¹,² 2.0 µg Pneumococcal polysaccharide serotype 19F¹,² 2.0 µg Pneumococcal polysaccharide serotype 22F¹,² 2.0 µg Pneumococcal polysaccharide serotype 23F¹,² 2.0 µg Pneumococcal polysaccharide serotype 33F¹,² 2.0 µg ¹ Conjugated to CRM₁₉₇ carrier protein. CRM₁₉₇ is a nontoxic mutant of diphtheria toxin (originating from Corynebacterium diphtheriae C7) expressed recombinantly in Pseudomonas fluorescens. ² Adsorbed on aluminium phosphate adjuvant.